Click here to get full coverage on $NRXS ($NRXS) Releases Q1 2026 Earnings - Quiver Quantitative

$NRXS ($NRXS) Releases Q1 2026 Earnings  Quiver Quantitative

$NRXS ($NRXS) Releases Q1 2026 Earnings - Quiver Quantitative

Click here to get full coverage on NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y - TradingView

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y  TradingView

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y - TradingView

Click here to get full coverage on NeurAxis (NRXS) 10K Form and Latest SEC Filings 2026 - MarketBeat

NeurAxis (NRXS) 10K Form and Latest SEC Filings 2026  MarketBeat

NeurAxis (NRXS) 10K Form and Latest SEC Filings 2026 - MarketBeat

Click here to get full coverage on NeurAxis will post first-quarter results before market open May 12 - Stock Titan

NeurAxis will post first-quarter results before market open May 12  Stock Titan

NeurAxis will post first-quarter results before market open May 12 - Stock Titan

Click here to get full coverage on Neuraxis Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga

Neuraxis Reports Q1 2026 Results: Full Earnings Call Transcript  Benzinga

Neuraxis Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga

Click here to get full coverage on NeurAxis Inc (NYSEARCA:NRXS) Shows Strong Technical and Fundamental Momentum - ChartMill

NeurAxis Inc (NYSEARCA:NRXS) Shows Strong Technical and Fundamental Momentum  ChartMill

NeurAxis Inc (NYSEARCA:NRXS) Shows Strong Technical and Fundamental Momentum - ChartMill

Click here to get full coverage on NRXS: Q1 2026 revenue up 80% year-over-year, with margin and adoption gains in covered markets - TradingView

NRXS: Q1 2026 revenue up 80% year-over-year, with margin and adoption gains in covered markets  TradingView

NRXS: Q1 2026 revenue up 80% year-over-year, with margin and adoption gains in covered markets - TradingView

Click here to get full coverage on NeurAxis, Inc. Reports 80% Revenue Growth in Q1 2026 Driven by CPT Code Assignment and Expanded Product Adoption - Quiver Quantitative

NeurAxis, Inc. Reports 80% Revenue Growth in Q1 2026 Driven by CPT Code Assignment and Expanded Product Adoption  Quiver Quantitative

NeurAxis, Inc. Reports 80% Revenue Growth in Q1 2026 Driven by CPT Code Assignment and Expanded Product Adoption - Quiver Quantitative

Click here to get full coverage on Craig-Hallum Maintains Neuraxis(NRXS.US) With Buy Rating - Moomoo

Craig-Hallum Maintains Neuraxis(NRXS.US) With Buy Rating  Moomoo

Craig-Hallum Maintains Neuraxis(NRXS.US) With Buy Rating - Moomoo

Click here to get full coverage on NeurAxis says its pain-treatment device now reaches 100M insured lives - Stock Titan

NeurAxis says its pain-treatment device now reaches 100M insured lives  Stock Titan

NeurAxis says its pain-treatment device now reaches 100M insured lives - Stock Titan

Click here to get full coverage on NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth - Sahm

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth  Sahm

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth - Sahm

Click here to get full coverage on NeurAxis Expands Payer Coverage with Four New Medical Policies - ChartMill

NeurAxis Expands Payer Coverage with Four New Medical Policies  ChartMill

NeurAxis Expands Payer Coverage with Four New Medical Policies - ChartMill

Click here to get full coverage on $NRXS stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

$NRXS stock is up 10% today. Here's what we see in our data.  Quiver Quantitative

$NRXS stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on 1.25 million more people gain access to NeurAxis' IBS pain device - Stock Titan

1.25 million more people gain access to NeurAxis' IBS pain device  Stock Titan

1.25 million more people gain access to NeurAxis' IBS pain device - Stock Titan

Click here to get full coverage on Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan

Medical tech firm NeurAxis schedules March 19 call on 2025 results  Stock Titan

Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan

Click here to get full coverage on Neuraxis (NRXS) executive makes small open-market share purchase - Stock Titan

Neuraxis (NRXS) executive makes small open-market share purchase  Stock Titan

Neuraxis (NRXS) executive makes small open-market share purchase - Stock Titan

Click here to get full coverage on Insider Purchase: Director at $NRXS Buys 286,138 Shares - Quiver Quantitative

Insider Purchase: Director at $NRXS Buys 286,138 Shares  Quiver Quantitative

Insider Purchase: Director at $NRXS Buys 286,138 Shares - Quiver Quantitative

Click here to get full coverage on $NRXS stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

$NRXS stock is down 11% today. Here's what we see in our data.  Quiver Quantitative

$NRXS stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 - Yahoo Finance UK

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026  Yahoo Finance UK

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 - Yahoo Finance UK

Click here to get full coverage on NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 - Yahoo Finance

NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026  Yahoo Finance

NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 - Yahoo Finance

Click here to get full coverage on NeurAxis, Inc. Declares Stock Dividend on Series B Preferred Stock - Quiver Quantitative

NeurAxis, Inc. Declares Stock Dividend on Series B Preferred Stock  Quiver Quantitative

NeurAxis, Inc. Declares Stock Dividend on Series B Preferred Stock - Quiver Quantitative

Click here to get full coverage on NeurAxis, Inc. Announces Preferred Stock Dividend - ChartMill

NeurAxis, Inc. Announces Preferred Stock Dividend  ChartMill

NeurAxis, Inc. Announces Preferred Stock Dividend - ChartMill

Click here to get full coverage on NeurAxis (NRXS) price target increased by 29.41% to 11.22 - MSN

NeurAxis (NRXS) price target increased by 29.41% to 11.22  MSN

NeurAxis (NRXS) price target increased by 29.41% to 11.22 - MSN

Click here to get full coverage on NeurAxis Expands At-The-Market Equity Offering Capacity - TipRanks

NeurAxis Expands At-The-Market Equity Offering Capacity  TipRanks

NeurAxis Expands At-The-Market Equity Offering Capacity - TipRanks

Click here to get full coverage on Neuraxis increases ATM capacity to $11.5M after $6.27M program sales - TradingView

Neuraxis increases ATM capacity to $11.5M after $6.27M program sales  TradingView

Neuraxis increases ATM capacity to $11.5M after $6.27M program sales - TradingView

Click here to get full coverage on NeurAxis Expands Payer Coverage with Four New Medical Policies - GlobeNewswire

NeurAxis Expands Payer Coverage with Four New Medical Policies  GlobeNewswire

NeurAxis Expands Payer Coverage with Four New Medical Policies - GlobeNewswire

Click here to get full coverage on NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - Yahoo Finance

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth  Yahoo Finance

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - Yahoo Finance

Click here to get full coverage on NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives - Yahoo Finance

NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives  Yahoo Finance

NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives - Yahoo Finance

Click here to get full coverage on Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Crowd Trend Signals - UBND thành phố Hải Phòng

Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Crowd Trend Signals  UBND thành phố Hải Phòng

Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Crowd Trend Signals - UBND thành phố Hải Phòng

Click here to get full coverage on Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges By GuruFocus - Investing.com Canada

Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges By GuruFocus  Investing.com Canada

Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges By GuruFocus - Investing.com Canada

Click here to get full coverage on This Small-Cap Healthcare Stock Is Up 300% in a Year and Is Quickly Gaining a Following - inkl

This Small-Cap Healthcare Stock Is Up 300% in a Year and Is Quickly Gaining a Following  inkl

This Small-Cap Healthcare Stock Is Up 300% in a Year and Is Quickly Gaining a Following - inkl

Click here to get full coverage on Is Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18 - Market Timing - Xã Thanh Hà

Is Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18 - Market Timing  Xã Thanh Hà

Is Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18 - Market Timing - Xã Thanh Hà

Click here to get full coverage on Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com

Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips  Investing.com

Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com

Click here to get full coverage on NRXS Stock Falters Amid Market Headwinds and Investor Uncertainty - StocksToTrade

NRXS Stock Falters Amid Market Headwinds and Investor Uncertainty  StocksToTrade

NRXS Stock Falters Amid Market Headwinds and Investor Uncertainty - StocksToTrade

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Neuraxis Inc. Faces Market Uncertainty Amid Financial Struggles - timothysykes.com

Neuraxis Inc. Faces Market Uncertainty Amid Financial Struggles  timothysykes.com

Neuraxis Inc. Faces Market Uncertainty Amid Financial Struggles - timothysykes.com

Click here to get full coverage on NRXS Stock Price, News & Analysis - Stock Titan

NRXS Stock Price, News & Analysis  Stock Titan

NRXS Stock Price, News & Analysis - Stock Titan

Click here to get full coverage on NeurAxis Expands Healthcare Reach with New VA and Insurance Agreements - StocksToTrade

NeurAxis Expands Healthcare Reach with New VA and Insurance Agreements  StocksToTrade

NeurAxis Expands Healthcare Reach with New VA and Insurance Agreements - StocksToTrade

Click here to get full coverage on NRXS Stock Price and Chart — AMEX:NRXS - TradingView

NRXS Stock Price and Chart — AMEX:NRXS  TradingView

NRXS Stock Price and Chart — AMEX:NRXS - TradingView

Click here to get full coverage on NRXS Forecast — Price Target — Prediction for 2027 - TradingView

NRXS Forecast — Price Target — Prediction for 2027  TradingView

NRXS Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on NeurAxis (NRXS) Insider Trading Activity 2026 - MarketBeat

NeurAxis (NRXS) Insider Trading Activity 2026  MarketBeat

NeurAxis (NRXS) Insider Trading Activity 2026 - MarketBeat

Click here to get full coverage on What is the current Price Target and Forecast for Neuraxis, Inc. (NRXS) - Zacks Investment Research

What is the current Price Target and Forecast for Neuraxis, Inc. (NRXS)  Zacks Investment Research

What is the current Price Target and Forecast for Neuraxis, Inc. (NRXS) - Zacks Investment Research

Click here to get full coverage on NeurAxis (NRXS) Institutional Ownership 2026 - MarketBeat

NeurAxis (NRXS) Institutional Ownership 2026  MarketBeat

NeurAxis (NRXS) Institutional Ownership 2026 - MarketBeat

Click here to get full coverage on NeurAxis (NRXS) Stock Price, News & Analysis - MarketBeat

NeurAxis (NRXS) Stock Price, News & Analysis  MarketBeat

NeurAxis (NRXS) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on NeurAxis: NRXS IPO, Health Care - Makes a non-surgical neuromodulation device for children with IBS-related pain. - renaissancecapital.com

NeurAxis: NRXS IPO, Health Care - Makes a non-surgical neuromodulation device for children with IBS-related pain.  renaissancecapital.com

NeurAxis: NRXS IPO, Health Care - Makes a non-surgical neuromodulation device for children with IBS-related pain. - renaissancecapital.com

Click here to get full coverage on Top NeurAxis (NRXS) Competitors 2026 - MarketBeat

Top NeurAxis (NRXS) Competitors 2026  MarketBeat

Top NeurAxis (NRXS) Competitors 2026 - MarketBeat

Click here to get full coverage on IPO Outlook: CUBT, ELEP, NRXS - Value The Markets

IPO Outlook: CUBT, ELEP, NRXS  Value The Markets

IPO Outlook: CUBT, ELEP, NRXS - Value The Markets

Click here to get full coverage on Neuraxis (NRXS) Stock: Down -5.75%, Support Test at $7.48 2026-05-15 - Trading Ideas - newser.com

Neuraxis (NRXS) Stock: Down -5.75%, Support Test at $7.48 2026-05-15 - Trading Ideas  newser.com

Neuraxis (NRXS) Stock: Down -5.75%, Support Test at $7.48 2026-05-15 - Trading Ideas - newser.com

Click here to get full coverage on The surprise hidden in Neuraxis (NRXS) last earnings report | Q4 2025: Earnings Beat Estimates - Put/Call Ratio - newser.com

The surprise hidden in Neuraxis (NRXS) last earnings report | Q4 2025: Earnings Beat Estimates - Put/Call Ratio  newser.com

The surprise hidden in Neuraxis (NRXS) last earnings report | Q4 2025: Earnings Beat Estimates - Put/Call Ratio - newser.com

Click here to get full coverage on The surprise hidden in Neuraxis (NRXS) last earnings report | Q4 2025: Earnings Beat Estimates - Most Watched Stocks - newser.com

The surprise hidden in Neuraxis (NRXS) last earnings report | Q4 2025: Earnings Beat Estimates - Most Watched Stocks  newser.com

The surprise hidden in Neuraxis (NRXS) last earnings report | Q4 2025: Earnings Beat Estimates - Most Watched Stocks - newser.com

Click here to get full coverage on What the smart money sees in Neuraxis (NRXS) that retail does not (Near Lows) 2026-05-08 - Shared Trade Alerts - newser.com

What the smart money sees in Neuraxis (NRXS) that retail does not (Near Lows) 2026-05-08 - Shared Trade Alerts  newser.com

What the smart money sees in Neuraxis (NRXS) that retail does not (Near Lows) 2026-05-08 - Shared Trade Alerts - newser.com

Click here to get full coverage on What the smart money sees in Neuraxis (NRXS) that retail does not (Near Lows) 2026-05-08 - Open Stock Picks - newser.com

What the smart money sees in Neuraxis (NRXS) that retail does not (Near Lows) 2026-05-08 - Open Stock Picks  newser.com

What the smart money sees in Neuraxis (NRXS) that retail does not (Near Lows) 2026-05-08 - Open Stock Picks - newser.com

Click here to get full coverage on NRXS Neuraxis Q4 loss narrows more than expected, but shares dip 0.11% despite EPS beat. - CFO Commentary - newser.com

NRXS Neuraxis Q4 loss narrows more than expected, but shares dip 0.11% despite EPS beat. - CFO Commentary  newser.com

NRXS Neuraxis Q4 loss narrows more than expected, but shares dip 0.11% despite EPS beat. - CFO Commentary - newser.com

Click here to get full coverage on NRXS Neuraxis Q4 loss narrows more than expected, but shares dip 0.11% despite EPS beat. - Post Announcement - newser.com

NRXS Neuraxis Q4 loss narrows more than expected, but shares dip 0.11% despite EPS beat. - Post Announcement  newser.com

NRXS Neuraxis Q4 loss narrows more than expected, but shares dip 0.11% despite EPS beat. - Post Announcement - newser.com

Click here to get full coverage on Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Short Setup - newser.com

Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Short Setup  newser.com

Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Short Setup - newser.com

Click here to get full coverage on Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Social Trade Signals - newser.com

Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Social Trade Signals  newser.com

Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Social Trade Signals - newser.com

Click here to get full coverage on Is Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18 - Community Breakout Alerts - newser.com

Is Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18 - Community Breakout Alerts  newser.com

Is Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18 - Community Breakout Alerts - newser.com

Click here to get full coverage on Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Bollinger Bands - newser.com

Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Bollinger Bands  newser.com

NRXS

Price Chart

Key Statistics

Technicals

About NRXS

Latest News

$NRXS ($NRXS) Releases Q1 2026 Earnings - Quiver Quantitative

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y - TradingView

NeurAxis (NRXS) 10K Form and Latest SEC Filings 2026 - MarketBeat

Advanced Charts

Top Gainers

Top Losers